Trials / Completed
CompletedNCT02300740
Pharmacokinetic Analysis of Nicotinamide Riboside
- Status
- Completed
- Phase
- EARLY_Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Aarhus University Hospital · Academic / Other
- Sex
- Male
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
Nicotinamide riboside is a newly discovered vitamin B3. The pharmacokinetics in humans is so far not analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Nicotinamide riboside | NIAGEN, ChromaDex |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2015-02-01
- First posted
- 2014-11-25
- Last updated
- 2015-02-27
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02300740. Inclusion in this directory is not an endorsement.